None listed
Conditions
Interventions
None listed
Sponsors
Asan Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: • Aged = 18 years at the initial NSCLC diagnosis • Patients who were diagnosed as NSCLC by histologic or cytologic confirmation from January 1, 2014 to December 31, 2017 • Patients who were diagnosed as Stage I, II and III resectable or unresectable NSCLC (according to Version 7 of the IASLC Staging)
Exclusion criteria
Exclusion criteria: • Patients who were diagnosed as small cell lung cancer • Patients whose medical records are not available for review • Patients who had not received any treatment (surgery, chemotherapy, radiotherapy, etc.) after diagnosis of stage I, II and III NSCLC
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the treatment patterns and real-world disease free survival (rwDFS) in the NSCLC patients with complete resection | — |
Secondary
| Measure | Time frame |
|---|---|
| Real-world Progression-free survival (rwPFS), 3 years overall survival (OS), patient’s characteristics, treatment pattern ;Rate and clinical outcomes including recurrence rate and 3 years survival rate, real-world Progression-free survival (rwPFS) of adjuvant chemotherapy treatment after surgery ;Treatment pattern and real-world Progression-free survival (rwPFS) after recurrence ;o 3 year overall survival(OS) in both resected and unresected population;Proportion and results of target gene (EGFR) mutation test ;The data of diagnostic evaluation and their results in stage I, II and III NSCLC;Analysis of patient’s characteristics, treatment in both resected and unresected population | — |
Countries
Korea, Republic of
Contacts
Public ContactWonjun Ji
Asan Medical Center
Outcome results
None listed